Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging
February 7th, 2014
Pulse wave velocity (PWV) measurement assesses arterial stiffness by a tonometry-based system that measures the speed with which arterial pressure wave travels along the arterial tree, typically approximating the time that it takes this wave to travel from the descending aorta (using the carotid artery as a surrogate) to the femoral artery. Carotid-femoral PWV increases two- to threefold across the adult lifespan.
Overview
This procedure assesses arterial stiffness through pulse wave velocity (PWV) measurements, which evaluate the speed of arterial pressure waves. By analyzing the time it takes for these waves to travel from the aorta to the femoral artery, researchers can gain insights into cardiovascular health and related conditions.
Key Study Components
Area of Science
- Cardiovascular health
- Arterial stiffness assessment
- Clinical diagnostics
Background
- Pulse wave velocity is a key indicator of arterial stiffness.
- Increased PWV is associated with aging and cardiovascular diseases.
- This method can also be relevant in studying cognitive disorders, renal disease, diabetes, and arthritis.
- Accurate measurement requires specialized equipment and analysis techniques.
Purpose of Study
- To measure arterial stiffness using PWV as a diagnostic tool.
- To explore the relationship between PWV and various health conditions.
- To provide a non-invasive method for assessing cardiovascular risk.
Methods Used
- Measurement of central blood pressure through pulse wave analysis.
- Attachment of ECG electrodes in a modified lead configuration.
- Acquisition of carotid and femoral pulse waveforms using a tonometer.
- Analysis of pressure wave speed with custom software.
Main Results
- PWV measurements correlate with arterial stiffness levels.
- The method provides insights into cardiovascular disease risk.
- Applications extend to other health conditions beyond cardiovascular issues.
- Results can inform clinical decision-making and patient management.
Conclusions
- PWV is a valuable tool for assessing arterial stiffness.
- It has implications for understanding cardiovascular health and disease.
- Further research may expand its applications in other medical fields.
Frequently Asked Questions
Executive Industry Relevance
Pulse wave velocity (PWV) testing provides a quantitative, noninvasive measure of central arterial stiffness, directly informing cardiovascular risk assessment in preclinical and translational research. This method enables high-confidence evaluation of vascular function, supporting mechanistic de-risking and target validation for cardiometabolic and systemic disease portfolios. Its reproducibility and standardized outputs position PWV as a critical tool for early discovery and cross-indication biomarker development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables quantitative interrogation of vascular stiffness as a mechanistic biomarker.
- Supports functional target validation for cardiovascular and systemic disease pathways.
- Facilitates predictive confidence in hypothesis-driven discovery programs.
Screening & Assay Development
- Provides standardized, reproducible measurements for assay development and validation.
- Delivers quantitative outputs suitable for cross-study and cross-cohort comparisons.
- Enables reliable evaluation of candidate interventions on arterial function.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints for cardiovascular and metabolic models.
- Supports translational biomarker continuity from preclinical to clinical studies.
- Informs risk-adjusted advancement decisions based on vascular health metrics.
Pipeline & Workflow Integration
PWV testing integrates into the discovery-to-preclinical continuum, bridging early mechanistic studies with translational biomarker strategies.
- Discovery Biology: Quantifies arterial stiffness to clarify vascular pathway involvement and de-risk targets.
- Screening: Supplies reproducible, quantitative readouts for candidate screening and assay standardization.
- Analytics: Generates statistical outputs (e.g., mean, standard deviation) for robust condition comparisons.
- Translational Research: Provides continuity for biomarker validation across preclinical and clinical phases.
- Enterprise Reuse: Establishes a reusable, standardized platform for vascular function assessment across programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in vascular research.
- Operational Value: Delivers standardized, scalable, and reproducible measurements for multi-site studies.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio management.
- Portfolio Impact: Supports risk-adjusted prioritization and cross-indication advancement decisions.
Implementation Considerations
- Requires expertise in vascular physiology and noninvasive hemodynamic measurement.
- Needs calibrated tonometry devices, ECG setup, and specialized analysis software.
- Demands cross-team standardization for measurement protocols and data interpretation.
- Adaptable to diverse preclinical and clinical model systems with appropriate validation.
- Accuracy depends on operator proficiency and adherence to quality thresholds (e.g., standard deviation <10%).
Biopharma FAQs
Chapters in this video
0:05
Title
1:06
Entering Patients into the Database
1:47
Central Blood Pressure Measurement Using Pulse Wave Analysis (PWA)
2:49
Arterial Stiffness Measurement Using Pulse Wave Velocity (PWV)
4:24
Shut Down
4:42
Results: Representative Carotid-femoral Pulse Wave Velocity Waveforms and Pulse Wave Analysis
5:48
Conclusion
